Last reviewed · How we verify
similar placebo to mebendazole
similar placebo to mebendazole is a Anthelmintic Small molecule drug developed by Swiss Tropical & Public Health Institute. It is currently in Phase 3 development for Treatment of intestinal infections caused by parasitic worms.
This drug works by inhibiting the action of a specific enzyme involved in the lifecycle of parasitic worms.
This drug works by inhibiting the action of a specific enzyme involved in the lifecycle of parasitic worms. Used for Treatment of intestinal infections caused by parasitic worms.
At a glance
| Generic name | similar placebo to mebendazole |
|---|---|
| Sponsor | Swiss Tropical & Public Health Institute |
| Drug class | Anthelmintic |
| Target | Beta-tubulin |
| Modality | Small molecule |
| Therapeutic area | Infectious Diseases |
| Phase | Phase 3 |
Mechanism of action
Mebendazole is a broad-spectrum anthelmintic that targets the microtubule function in the parasite's cell cycle. By inhibiting this enzyme, the drug disrupts the parasite's ability to reproduce and survive within the host. This mechanism of action is similar to that of mebendazole, but with a different chemical structure.
Approved indications
- Treatment of intestinal infections caused by parasitic worms
Common side effects
- Gastrointestinal upset
Key clinical trials
- Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections (PHASE3)
- Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- similar placebo to mebendazole CI brief — competitive landscape report
- similar placebo to mebendazole updates RSS · CI watch RSS
- Swiss Tropical & Public Health Institute portfolio CI
Frequently asked questions about similar placebo to mebendazole
What is similar placebo to mebendazole?
How does similar placebo to mebendazole work?
What is similar placebo to mebendazole used for?
Who makes similar placebo to mebendazole?
What drug class is similar placebo to mebendazole in?
What development phase is similar placebo to mebendazole in?
What are the side effects of similar placebo to mebendazole?
What does similar placebo to mebendazole target?
Related
- Drug class: All Anthelmintic drugs
- Target: All drugs targeting Beta-tubulin
- Manufacturer: Swiss Tropical & Public Health Institute — full pipeline
- Therapeutic area: All drugs in Infectious Diseases
- Indication: Drugs for Treatment of intestinal infections caused by parasitic worms
- Compare: similar placebo to mebendazole vs similar drugs
- Pricing: similar placebo to mebendazole cost, discount & access